St Louis Institute of Nanomedicine/>

The recent emergence of nanoscience as a key approach to innovation in advanced
materials has sparked a similar interest in the application of its principles to
the fields of biomedical diagnostics, therapeutics, and basic cell physiology.

The overarching goal of the new St Louis Institute of Nanomedicine sponsored by
the Missouri Life Sciences Research Board is to advance the safe and effective
use of nanotechnologies to reduce death and suffering from human disease.

The St. Louis Institute for Nanomedicine is a joint venture sponsored principally
by leading local academic institutions that will assemble a broad base of
regional expertise in the nanotechnology, medicine, technology transfer, and
education to create novel solutions to complex health care problems.

Founding partners include: WashingtonFounding partners include: Washington University, University of Missouri at St
Louis, St Louis University, and the St Louis Community Colleges. The Institute
will develop viable approaches to foster collaborations between multinational
industrial and regional academic partners, and seek to leverage local financial
and community resources to grow the regional biotechnology enterprise.